cardiovascular innovation

RAMAT-GAN, Israel, July 16, 2026 Galmed Pharmaceuticals Ltd. has announced the breakthrough development of a novel lipid nanoparticle (LNP)...

FLAGSTAFF, Ariz., May 11, 2026 Corvention announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance...

FORT MILL, S.C., March 6, 2026 Catheter Precision, Inc., a U.S.-based medical technology company specializing in cardiac electrophysiology innovations,...

Houston, Texas | January 2026 — HeartX, a leading cardiovascular innovation accelerator, has officially opened applications for its 2026...

Princeton, N.J., November 4, 2025 – Bristol Myers Squibb (NYSE: BMY) announced a major scientific milestone with the presentation...